Related Experiment Video
Updated: Jun 15, 2026
06:41
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Genomic variants associated with primary biliary cirrhosis
Carlo Selmi1, Natalie J Torok, Andrea Affronti
1Department of Translational Medicine, Università degli Studi di Milano, Milan, Italy. carlo.selmi@unimi.it.
Genome Medicine
|March 3, 2010
Summary
Primary biliary cirrhosis (PBC) is an autoimmune liver disease. This review critically examines genetic association studies in PBC, highlighting the need for more powerful, validated research to understand disease causes.
Area of Science:
- Hepatology
- Immunology
- Genetics
Background:
- Primary biliary cirrhosis (PBC) is an autoimmune liver disease causing bile duct injury and cirrhosis.
- PBC pathogenesis involves immune activation against lipoylated 2-oxoacid dehydrogenase complexes.
- Genetic susceptibility and environmental factors are implicated in PBC onset.
Purpose of the Study:
- To critically review genetic association studies in primary biliary cirrhosis.
- To evaluate the power and validation of existing PBC genetic research.
- To predict future directions for genetic studies in PBC.
Main Methods:
- Systematic literature review of genetic association studies in PBC.
- Critical analysis of study methodologies, statistical power, and validation.
- Synthesis of findings to identify trends and knowledge gaps.
Main Results:
- Numerous genetic association studies in PBC have reported findings.
- Many studies lack sufficient statistical power and independent validation.
- Recent genome-wide association studies require further confirmation.
Conclusions:
- Current genetic research in PBC is extensive but often limited by methodology.
- Robust, well-powered, and validated genetic studies are crucial for understanding PBC etiology.
- Future research should focus on independent replication and larger cohorts.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...